Business Wire

CA-ANDERSEN-GLOBAL

13.7.2024 16:43:35 CEST | Business Wire | Pressemeddelelse

Del
Andersen Global forstærker sin afrikanske platform og tilføjer værdiansættelseskapacitet i Nigeria og Sydafrika

Andersen Global har tilføjet værdiansættelseskapacitet i Afrika og styrket sin overordnede regionale dækning ved at tilknytte ​​to nye samarbejdsvirksomheder – Nelson Thorpe Alonge i Nigeria og Valeo Capital i Sydafrika. Med disse tilføjelser markerer Andersen sine første udbud af værdiansættelsesservice i Afrika og og øger dermed virksomhedens udbud af global værdiansættelse i Nordamerika, Europa, Latinamerika, Mellemøsten og Asien.

Nelson Thorpe Alonge udbyder en komplet portefølje af værdiansættelse af aktiver, der dækker jord og bygninger, anlæg og udstyr, maritime aktiver, olie og gas, luftfart, ejendomsinvesteringer, ejendomsmæglervirksomhed, salg og opkøb, ejendoms- og facilitetsadministration samt rådgivning om ejendomsudstykning. Under ledelse af seniorpartner Victor Alonge betjener virksomheden selskaber, internationale agenturer, diplomatiske enheder, stater, statslige agenturer og personer med stor nettoformue.

"Kundernes succes og tilfredshed står i centrum af vores forretningsstrategi," siger Victor. "Vores samarbejde med Andersen Global er en milepæl for vores virksomhed og viser, at vi altid engagerer os maksimalt i forhold til vores kunder, når vi udvider vores virkeområde til at levere perfekte og omfattende værdiansættelsesløsninger globalt."

Valeo Capital er stiftet af de to partnere Riaan van Heerden og David Tosi og er en specialiseret virksomhed, der arbejder tæt sammen med kunder lige fra greenfieldvirksomheder til børsnoterede selskaber. Virksomheden yder omfattende virksomhedsfinansiering og -rådgivning, herunder fusioner og opkøb, BEE-ejerskabsstrukturering (black economic empowerment), værdiansættelse af virksomheder, due diligence og kapitalrejsning.

"Vi er stolte af den ressourcestyrke, pålidelighed og professionelle indsigt, vi giver til kunder og ønsker at fortsætte med at udvide vores udbud til kunder lokalt og globalt," siger Riaan. "Vores samarbejde med Andersen Global er en yderligere styrkelse af vores teams engagement i at yde klassens bedste service og fastholder vores konkurrencefordel i regionen."

Global Chairman og CEO for Andersen Mark L. Vorsatz siger: "Nelson Thorpe Alonge og Valeo Capital har konsekvent demonstreret deres forpligtelse på god forvaltning og kundeservice, og har skilt sig ud som førende på markedet. Både Nigeria og Sydafrika er som altid vigtige markeder, og virksomhedernes ekspertise er vigtig for vores globale ekspansionsstrategi og for at opfylde de skiftende værdiansættelseskrav fra kunder både regionalt og i udlandet."

Andersen Global er en international sammenslutning af juridisk adskilte og uafhængige medlemsvirksomheder, der består af skattejurister samt skatte- og værdiansættelseseksperter i hele verden. Andersen Global, der blev etableret i 2013 af den amerikanske medlemsvirksomhed Andersen Tax LLC, har nu mere end 17.000 eksperter i hele verden og en tilstedeværelse på over 475 lokaliteter gennem sine medlemsvirksomheder og samarbejdsvirksomheder.

Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.

For at se dette indhold fra cts.businesswire.com, så skal du give din accept på toppen af denne side.

Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20240711008688/da/

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

SLB Launches ExaCT Electrical Downhole CT Control System24.8.2026 13:02:00 CEST | Press release

New platform brings real-time electrical control to coiled tubing intervention, enabling greater precision, visibility and efficiency across intervention operations SLB (NYSE: SLB) today launched the ExaCT™ electrical downhole coiled tubing (CT) control system, an advanced intervention platform that introduces real-time electrical control to coiled tubing operations. By replacing pressure-dependent hydraulic actuation with electrical communication, power delivery and telemetry, the ExaCT system gives operators greater visibility, precision and control, helping improve intervention execution and reservoir access. The ExaCT system combines electrical power, telemetry and downhole measurements to enable communication with, actuation of and verification of downhole tools throughout an intervention. Continuous communication across the toolstring enables on-demand tool actuation across a wide range of intervention applications, including extended-reach and multilateral wells. The increased p

Wolters Kluwer Transforms Trusted Legal Content Into Structured, AI-Ready Intelligence That Powers the Next Wave of Legal AI24.8.2026 13:01:00 CEST | Press release

By transforming authoritative legal content into structured legal intelligence, Wolters Kluwer gives AI the context and relationships needed to deliver deeper research and higher-quality results Wolters KluwerLegal & Regulatory today announced the next evolution of Libra by Wolters Kluwer, its all-in-one Legal AI Workspace. By transforming authoritative legal sources, expert commentaries, and practical guidance into structured legal intelligence, Wolters Kluwer is making the relationships across the full breadth of its expert legal sources more explicit. This will enable deeper contextual research, more comprehensible answers, and workflow-ready results across legal work. Following the integration of Wolters Kluwer content into the Libra AI workspace in the first half of 2026, laws, rulings, expert commentaries, and practical guidance will now be linked to one another and to the matter at hand, creating a connected knowledge graph of expert-curated and authoredlegal knowledge that AI c

Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization24.8.2026 10:00:00 CEST | Press release

Daiichi Sankyo (TSE: 4568) today announced the appointment of Markus Kosch, MD, as Head of Europe Business, effective April 1, 2027. In this role, he will lead the company's European business within the new globally integrated Commercialization Unit and serve as General Manager of Daiichi Sankyo Europe GmbH, with legal responsibility for the company in Europe. The appointment reflects the next phase of growth of Daiichi Sankyo under its Five-Year Business Plan and the establishment of a new Commercialization Unit. Within this new structure, Markus Kosch will bring together the Oncology and Specialty businesses in Europe under one integrated leadership model to help bring innovative medicines to more patients across the region. For the past five years, Markus Kosch has led the Daiichi Sankyo Oncology Business Division in Europe and Canada, overseeing a period of significant growth and preparing the organization for an increasingly expanding oncology portfolio. Prior to joining Daiichi S

European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union24.8.2026 09:01:00 CEST | Press release

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the European Commission (EC) has granted marketing authorization for DAYBU (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older, making it the first and only treatment approved for Rett syndrome in the European Union (EU). “The approval of DAYBU marks a significant milestone for the Rett syndrome community in the EU and advances our mission to bring this innovative treatment to patients and families who have long faced a profound unmet medical need,” said Catherine Owen Adams, Acadia’s Chief Executive Officer. “For people living with Rett syndrome, a devastating rare neurodevelopmental disorder, there have been no approved treatment options in the EU. We are proud to make DAYBU available and look forward to supporting patients, caregivers, and healthcare providers gain access to treatment." The DAYBU marketing authorization in the EU is prim

ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 124.8.2026 08:36:00 CEST | Press release

Discovered by Takeda in Japan, ORZEYFUL has the Potential to Redefine Care Beyond Individual Symptom Management for Adults Living with Narcolepsy Type 1 (NT1) Landmark Phase 3 Studies Demonstrated Significant and Meaningful Improvements Across the Full Range of NT1 Symptoms Evaluated in Clinical Trials Compared to Placebo Milestone Marks Third Major Regulatory Approval Secured for ORZEYFUL Around the World Takeda (TOKYO:4502/NYSE:TAK) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults. ORZEYFUL is a first-in-class oral orexin receptor 2 (OX2R) agonist and the only medicine indicated in Japan to treat the disease holistically rather than individual symptoms. The discovery of this new class of medicine originated in Takeda's laboratories in Japan. Takeda is proceeding with launch preparations and expects to make ORZEYFUL available as quickly

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye